Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer

BACKGROUND: Modified FOLFIRINOX and gemcitabine plus nab-paclitaxel (GEM-NAB) have been recommended as first-line therapies for advanced pancreatic cancer (PC). Due to the lack of evidence to directly compare them, we conducted this network meta-analysis to indirectly compare the effectiveness and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiayuan, Hua, Qingling, Wang, Haihong, Zhang, Dejun, Zhao, Lei, Yu, Dandan, Pi, Guoliang, Zhang, Tao, Lin, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306351/
https://www.ncbi.nlm.nih.gov/pubmed/34301232
http://dx.doi.org/10.1186/s12885-021-08605-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306351/
https://www.ncbi.nlm.nih.gov/pubmed/34301232
http://dx.doi.org/10.1186/s12885-021-08605-x

Ejemplares similares